Jeffrey A. Deiuliis

Popular Topics

Intellectual Property

DETAILS

United States

www.dinslaw.com

+1 614 628 6880

AUTHORS CONTENT

Federal Circuit Clarifies §101 Eligibility for Recombinant Cells in Regenxbio v. Sarepta

United States IP

Mondaq uses cookies on this website. By using our website you agree to our use of cookies as set out in our Privacy Policy.

Learn More